Stocks in play: Knight Therapeutics Inc.
Will release its fourth-quarter and year-end 2023 financial results on Thursday, March 21, prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Knight Therapeutics Inc. shares T.GUD are trading unchanged at $5.28.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.